secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001193125-24-278985
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech adopts amended and restated bylaws effective December 13, 2024
-------------------------------------------------------------------------

- Amended bylaws revise procedural mechanics for stockholder director nominations and other business proposals.
- New provisions address compliance with Rule 14a-19 under the Exchange Act regarding universal proxy.
- Updates to stockholder meeting procedures and director eligibility requirements are included.
- Changes conform to recent amendments to the Delaware General Corporation Law.
- Other ministerial and clarifying amendments were made effective immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524278985/0001193125-24-278985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312524278985/d896239d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-278985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer